Ford is recalling almost 388,000 vehicles due to safety concerns with the second-row seats.

Ford is recalling almost 388,000 vehicles due to safety concerns with the second-row seats.

The federal regulators have announced that Ford is initiating a recall for roughly 388,000 SUVs due to an issue with the second-row easy-access seats, which could potentially heighten the risk of injury.

According to a recall notice from the National Highway Traffic Safety Administration (NHTSA), around 387,911 vehicles are impacted, specifically certain 2020-2026 Ford Explorers and 2020-2027 Lincoln Aviator models.

NHTSA pointed out that there could be a defect leading to unexpected tilting or sliding of the second-row seats while the vehicle is in motion.

“Unexpected seat movement could hinder proper restraint of occupants during a crash, raising the injury risk,” they stated.

Furthermore, they specified, “The switch for the easy-access second-row outboard seat may get stuck, which could cause the seat to unlatch, tilt, or slide unexpectedly.”

Vehicle owners are urged to be on the lookout for several warning signs. For instance, if the button gets jammed in the down position, it might hinder the use of the Easy Entry feature or prevent returning the seat to its regular position after it’s been used.

As of June 16, 2026, Ford’s Critical Concerns Review Group has documented 14 reports of the second-row seats shifting unintentionally while driving. Notably, six of these incidents involved vehicles that had already undergone prior recall fixes, while eight pertained to those not covered previously.

Surprisingly, Ford has stated that they are not aware of any accidents or injuries stemming from this situation.

Owners will be instructed to visit a Ford or Lincoln dealership where they will receive a free replacement of the second-row easy-entry switch bezel and housing with an updated design.

A notification letter regarding this recall will be sent to owners later this month, followed by another letter in January detailing the remedies.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News